Aclarion (ACON) has received a Notice of Allowance from the United States Patent and Trademark Office for its 24th issued US patent. Whereas ...

It is hoped that this presentation of the basics of NMR spectroscopy is more accessible than the commonly found one in textbooks or websites. Almost all samples give a NMR spectrum This facility deals ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company, announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent ...

Proton Magnetic Resonance Spectroscopy (1H-MRS) is a non-invasive imaging technique that allows researchers to measure the concentrations of various metabolites in the brain, providing insights ...

Aclarion, Inc. (NASDAQ: ACON) shares cleared breakeven Tuesday, as the health-care technology company announced it has received a Notice of Allowance from the United States Patent and Trademark Office ...

Magnetic Resonance Spectroscopy (MRS) is a powerful non-invasive imaging technique that allows researchers to study the metabolic processes in skeletal muscle. This technique provides insights ...

Denmark: A recent study published in the Journal of Diabetes and its Complications has explored the role of kidney fat ...

The Nuclear Magnetic Resonance Spectroscopy Lab features a state-of-the-art JEOL 400 MHz NMR equipped with auto sampling and automatic tuning & matching. The instrument can perform temperature and ...

In a challenging year for Aclarion, the medical technology company's stock has plummeted to a 52-week low, trading at $4.41. According to InvestingPro data, the company maintains a healthy liquidity ...

Northwestern Medicine is a global leader in clinical trial research, including spineCLARITY is a randomized study designed to demonstrate ...

A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with ...

We recently compiled a list of the 12 AI News and Ratings You Should Not Miss. In this article, we are going to take a look ...